VerAvanti Overview
- Founded
-
2012
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Debt - PPP
- Investors
-
2
VerAvanti General Information
Description
Developer of a scanning fiber endoscope device designed to identify the causes of strokes and cardiac events. The company's device consists of an imaging station and a tiny catheter that is designed to take high definition images, enabling doctors and surgeons to have a peek into hidden intra-vascular anatomy and visually identify potential risks for stroke and cardiovascular risks.
Contact Information
Website
www.veravanti.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
- 2260 152nd Avenue North East
- Suite 200
- Redmond, WA 98052
- United States
+1 (425) 000-0000
VerAvanti Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Debt - PPP | 29-Apr-2020 | 00.000 | Completed | Startup | ||
| 4. Capitalization | 17-Jul-2017 | 000 | 00.000 | Completed | Startup | |
| 3. Grant | 01-Jun-2017 | 00000 | 00000 | Completed | Startup | |
| 2. Angel (individual) | 25-May-2017 | $540K | $540K | Completed | Startup | |
| 1. Accelerator/Incubator | 28-Jun-2014 | Completed | Startup |
VerAvanti Patents
VerAvanti Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210239451-A1 | Forward looking rgb/optical coherence tomography duplex imager | Pending | 30-Jan-2020 | 00000000000 | |
| US-11047671-B1 | Forward looking rgb/optical coherence tomography duplex imager | Active | 30-Jan-2020 | 00000000000 | |
| US-9258108-B2 | Closed loop, optical feedback synchronization system for imaging applications | Active | 24-Mar-2014 | 0000000000 | |
| US-20150270945-A1 | Closed loop, optical feedback synchronization system for imaging applications | Granted | 24-Mar-2014 | 0000000000 | |
| CA-2980534-A1 | Optical feedback synchronization system for imaging applications | Abandoned | 24-Mar-2014 | H04L7/0075 |
VerAvanti Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Gerald McMorrow | Founder, Board Member & Chief Executive Officer | ||
| David Odom | Chief Financial Officer |
VerAvanti Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| David Auth Ph.D | Self | Board Member | 000 0000 |
| Frederic Moll MD | Self | Board Member | 000 0000 |
VerAvanti Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
VerAvanti Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| National Institutes of Health | Government | 000 0000 | 000000 0 | ||
| UW CoMotion | Accelerator/Incubator | 000 0000 | 000000 0 |